SIGLEC15 (sialic acid-binding immunoglobulin-type lectin 15) is an emerging immunosuppressive transmembrane protein that is highly expressed in various solid tumors, including pancreatic cancer, thyroid cancer, bladder cancer, and glioma. Here, SIGLEC15 is linked to urinary bladder carcinoma.